'AstraZeneca ditches vaccine plant' and Trump's EU tariff threat
The Financial Times leads on AstraZeneca's decision to scrap plans for a new vaccine manufacturing plant in Liverpool, calling it "a blow to the government's growth agenda". The paper says executives have warned that policies pursued by the government will make the UK a less attractive place to invest.
AstraZeneca ditches plan to build new UK vaccine plant
AstraZeneca is pulling out of its plans to build a £450mn UK vaccine manufacturing plant after months of wrangling with British officials about state investment for the Merseyside project, in a major blow to Prime Minister Sir Keir Starmer’s government.
AstraZeneca Plc abandoned plans to invest £450 million ($558 million) in a UK vaccine manufacturing plant, following ...
When Oxford University developed the AstraZeneca vaccine, Dr Sue Pavord, a consultant haematologist, was so eager for it to ...
In substance and timing, AstraZeneca's decision to cancel a planned expansion of its flu vaccine facility at Speke is a blow ...
In a blow to Treasury chief Rachel Reeves at the end of a week when she trumpeted the government's plans to bolster British ...
Rachel Reeves was dealt yet another blow after AstraZeneca cancelled a planned £450 million investment in a vaccine manufacturing plant. The chancellor came under fire on GB News for "making an ...
All nine macaques given the control developed severe disease when exposed to bird flu, as did all given the smallest dose of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback